Mesenchymal stem cell (MSC) transplantation by intramyocardial injection has been proposed as a promising therapy strategy for cardiac repair after myocardium infarction. However, low retention and survival of grafted MSCs hinder its further application. In this study, copolymer with N-isopropylacrylamide/acrylic acid/2-hydroxylethyl methacrylate-poly("-caprolactone) ratio of 88:9.6:2.4 was bioconjugated with type I collagen to construct a novel injectable thermosensitive hydrogel. The injectable and biocompatible hydrogel-mediated MSC transplantation could enhance the grafted cell survival in the myocardium, which contributed to the increased neovascularization, decreased interstitial fibrosis, and ultimately improved heart function to a significantly greater degree than regular MSC transplantation. We suggest that this novel hydrogel has the potential for future stem cell transplantation.
Introduction
Bone marrow mesenchymal stem cell (MSC) transplantation has been proposed as one of the potential approaches to treat ischemic heart diseases. 1 Previous studies suggested that intramyocardial injection of stem cells allows targeted cell delivery into the areas of interest, which has been proved to be more advantageous for cardiac repair over intravenous or intracoronary delivery route. 2, 3 However, it is demonstrated that only less than 10% of transplanted cells stayed in situ a few hours after intramyocardial injection. 4 The low cell retention rate and the massive cell redistribution into other organs may lead to the limited efficacy of the stem cell transplantation and hinder its clinical application for infarct myocardium repair. 5, 6 Hence, the approach of intramyocardial injection still needs to be optimized.
Injectable hydrogel has been developed as a novel and effective approach to deliver stem cells for its tissue-like mechanical property, remarkable biocompatibility, and, most important, injectability. 7 So far, both natural macromolecules and synthetic polymers have been utilized to produce injectable hydrogels. [8] [9] [10] [11] As one of the most widely used injectable hydrogels, poly-N-isopropylacrylamide (PNIPAAm) is a thermosensitive intelligent material which undergoes a reversible sol-gel transition around 32 C in an aqueous condition, converting from flowable solution to hydrogel when heated above its lower critical solution temperature (LCST). 12 However, PNIPAAm still needs to be optimized to improve the thermosensitive property and biocompatibility for clinical application. Recently, we copolymerized N-isopropylacrylamide (NIPAAm), acrylic acid (AAc), and macromer 2-hydroxylethyl methacrylate-poly("-caprolactone) (HEMAPCL) to synthesize poly(NIPAAm-co-HEMA-co-HEMAPCL) copolymer. And type I collagen was then bioconjugated with the copolymer to enhance the biocompatibility further. We found that the copolymer with NIPAAm/AAc/HEMAPCL ratio of 88:9.6:2.4 exhibited excellent biological intelligence and low cytotoxicity in vitro. 13 In the present study, we utilized the novel hydrogel to deliver MSCs to infarct myocardium. We hypothesized that the hydrogel can enhance cell retention, decrease cell redistribution to other organs, and, therefore, improve the cardiac repair.
Materials and methods

Preparation of MSCs
All animal experiments were approved by Institutional Review Board and Institutional Animal Care and Use Committee Protocols of Fudan University. The syngenic mouse strain C57/BL6 weighing 20-25 g was used to avoid rejection.
Bone marrow was flushed from tibias and femurs of male C57/BL6. Whole marrow cells were cultured in MesenCult basal medium that was supplemented with MSCs stimulatory supplements (Cyagen Biosciences Inc., CA, USA). The non-adherent cells were removed by a medium change at 36 and 72 h. After the cells grow to fourth passages, the purity of the cells was detected by immunostaining and flowcytometry. The cells were incubated with 1 mL monoclonal fluorescein isothiocyanate (FITC)-conjugated antibodies against CD34, CD45, CD44, and CD105 (BD, CA, USA), then, analyzed using flow cytometer (FACS, AriaII, BD, NJ, USA) and double immunofluorescent labeling techniques combined with confocal laser scanning microscope (Olympus, Tokyo, Japan).
To track the grafted cells, MSCs were transfected with lentiviral vector carrying ubiquitin promoter driving firefly luciferase (Fluc), and then labeled with 4 0 ,6 0 -diamidino-2-phenylindole hydrochloride (DAPI) before transplantation.
Synthesis of poly(NIPAAm-co-HEMA-co-HEMAPCL) copolymer
The synthesis of poly(NIPAAm-co-HEMA-co-HEMAPCL) copolymer was carried out by free radical polymerization of NIPAAm, AAc, and HEMAPCL with a feed ratio of 88:9.6:2.4 (NIPAAm/AAc/HEMAPCL). And the copolymer was then used to conjugate type I collagen by 1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC)/N-Hydroxysuccinimide (NHS) crosslinking. 13 Morphology of dehydrated poly(NIPAAm-co-AAc-co-HEMAPCL)-type I collagen was observed by utilizing scanning electron microscopy (SEM). The dehydrated hydrogel was immersed into liquid nitrogen and lyophilized at À50 C. Then, the gel was gold-coated and viewed using a JSM-6330F SEM (JEOL, Peabody, MA, USA) operated at 10 kV accelerating. Storage modulus and viscosity were determined from 20 C to 40 C. And water content and remaining of the hydrogel were tested from day 0 to day 14. 13
Myocardial infarction model and cell transplantation
Myocardial infarction was created in adult female C57/BL6 mice by ligating the left coronary artery. 14 The copolymer was dissolved in phosphate-buffered saline buffer solution with the concentration of 15 wt% at 4 C before injection. Ten minutes after myocardial infarction, saline (group 1, n ¼ 8), hydrogel solution (group 2, n ¼ 8), 1 Â 10 6 MSCs (group 3, n ¼ 8), or 1 Â 10 6 MSCs mixed with hydrogel solution (group 4, n ¼ 8), were injected into the periinfarct region.
Optical bioluminescence imaging of survival MSCs in live mice
Bioluminescence imaging (BLI) was performed using the IVIS200 (Xenogen, CA, USA) System to evaluate the survival MSCs in live animals. Recipient mice were anesthetized with isoflurane, shaved, and placed in the imaging chamber. Animals were then scanned for bioluminescence spot at 30 min after intraperitoneal injection of the reporter probe D-luciferin (300 mg/kg body weight). The experiment was performed repetitively at 2 h, 1 day (1 d), and 28 days (28 d). Bioluminescence was quantified in units of maximum photons per second per centimeter squared per steradian (PÁs À1 Ácm À2 Ásr À1 ) from a fixed region of interest.
Heart function assessment
Heart function was assessed by transthoracic two-dimensional echocardiographic analysis using an echocardiograph (Vevo770, VisualSonics, Toronto, Canada) immediately after infarction model (Baseline) and 28 d after cell transplantation. Parasternal long-axis views were obtained to view the regional wall-motion abnormalities. Short-axis M-mode views were obtained perpendicular to the midventricular level, with sweep speeds of 200 mm/s confirmed by means of two-dimensional echocardiography. Left ventricular ejection fraction (LVEF) and left ventricular fractional shortening (LVFS) were computed as:
Histology
After heart function assessment, hearts were sectioned into five segments parallel to the apex-base axis. DAPI-labeled MSCs were observed directly. And interstitial fibrosis was evaluated by Masson trichrome staining. And the peri-infarct capillary densities were measured by staining for PECAM-1 (Santa Cruz Biotechnology) on the DAPIpositive slides.
Statistical analysis
The data were analyzed with SPSS 17.0 software (SPSS, Chicago, IL, USA). All values were expressed as the mean AE standard error of the mean. One-way analysis of variance with the post hoc Bonferroni test was performed to assess the significant difference among multiple groups. The significant difference between two groups was evaluated using the Student's t-test.
Results
Characterizations of isolated MSCs
After four passages of MSCs, flow cytometry and immunostaining results showed absence of CD34, CD45, indicating depletion of hematopoietic cells within the MSC. Moreover, 97.70% and 94.92% of these MSCs expressed the markers CD44 and CD105, respectively, when gated for controlat 1% by means of flow cytometric analysis (Figure 1 The efficiency of DAPI and Fluclabeling was 100% and 89.5%, respectively. Trypan blue dye exclusion showed greater than 95% viability of the cell preparations before transplantation.
Characterizations of poly(NIPAAm-co-HEMA-co-HEMAPCL) copolymer-type I collagen
The interior morphology of the PNIPAAm (Figure 2(a) ) and hydrogel (Figure 2(b) ) was observed under SEM. The storage modulus and viscosity from 20 C to 40 C were shown in Figure 2(c) and (d) . And the water content and remaining from day 0 to day 14 were shown in Figure 2 (e) and (f).
The hydrogel was flowable solution below 27 C and converted to hydrogel with relatively high tensile strength when it was heated to 37 C (Figure 3 ).
Survival MSCs in vivo
In the myocardium, group 4 demonstrated significantly higher optical BLI signals than group 3 [2h: (7.07 AE 0.96) Â 10 6 versus (1.82 AE 0.44) Â 10 6 P s À1 cm À2 sr À1 ; 1d: (2.82 AE 0.149) Â 10 6 versus (8.29 AE 1.46) Â 10 5 P s À1 cm À2 sr À1 ; 28 d: (1.13 AE 0.21) Â 10 6 versus 0 P s À1 cm À2 sr À1 ] (P < 0.01) (Figure 4(a) and (c)). DAPI-labeled MSCs in group 4 were observed in myocardium at 2 h, 1 d, and 28 d (Figure 4(b) ).
In the outside of the myocardium, higher signals [2h:(3.59 AE 0.46) Â 10 6 P s À1 cm À2 sr À1 ;1 d:
(1.93 AE 0.50) Â 10 6 P s À1 cm À2 sr À1 ; 28 d: (1.30 AE 0.72) Â 10 5 P s À1 cm À2 sr À1 ] were found in group 3 as compared to the signals in group 4 [2h:0 P s À1 cm À2 sr À1 ; 1 d: (5.38 AE 0.11) Â 10 4 ;28 d: (6.30 AE 0.25) Â 10 4 P s À1 cm À2 sr À1 ] (P < 0.05 for 2 h and 1 d; P > 0.05 for 28 d) (Figure 4(a) and (c)).
Interstitial fibrosis and angiogenesis
At 28 d after infarction, the capillary density based on PECAM-1 immunostaining in group 4 (78.65 AE 5.00 per field) was higher than those in other groups (group 1: 21.88 AE 1.89 per field; group 2: 25.46 AE 4.52 per field) (P < 0.01) (group 3: 53.33 AE 5.77per field) (P < 0.05) ( Figure  5(a) and (b) ). The collagen volume fraction based on Masson trichrome staining in group 4 showed significantly less than other groups (group 1: 82.99 AE 4.55%; group 2: 78.92 AE 5.87%) (P < 0.01) (group 3: 53.22 AE 6.23%) (P < 0.05) ( Figure 5(a) and (c)).
Heart function
There was no obvious difference in baseline heart performance (LVFS and LVEF) among the different groups (P > 0.05). LVFS and LVEFin group 3 (17.48 AE 0.91%, 36.83 AE 1.68%) improved significantly compared with those in group 1 (10.59 AE 0.51%, 23.22 AE 1.10%, P < 0.01) and group 2 (11.60 AE 0.70%, 25.34 AE 1.41%, P < 0.01). Furthermore, LVEF and LVFS in group 4 (27.55 AE 0.88%, 53.81 AE 1.24%) showed greater enhancement than those in group 3 (P < 0.01) (Figure 5(a) and (b) ).
Discussion
As a widely used transplantation strategy, intramyocardial injection of stem cells needs to be optimized. In our present study, we constructed a novel thermoresponsive intelligent hydrogel by poly(NIPAAm-co-AAc-co-HEMAPCL) copolymer and type I collagen. The novel hydrogel was then used to deliver MSCs to mice ischemic myocardium and promoted cardiac repair successfully.
An ideal hydrogel for stem cell transplantation should be injectable with an intelligent thermosensitive property. 15 Our novel hydrogel was composed of poly(NIPAAm-co-AAc-co-HEMAPCL) copolymerand-type 1 collagen. To be specific, NIPAAm provided the thermal sensitivity of the hydrogel, HEMAPCL served as biodegradable pieces, and AAc was used to enhance the hydrophilicity and adjust the LCST. 13, 16 In our previous work, we constructed a series of thermosensitive copolymers, which were prepared by varying the molar ratio (R ratio) of the hydrophilic monomer AAc and the hydrophobic macromer HEMAPCL. We found that the copolymer with NIPAAm/AAc/HEMAPCL ratio of 88:9.6:2.4 was considered as the best candidate for injectable properties. 13 In the present study, poly(NIPAAm-co-AAc-co-HEMAPCL) exhibited satisfied biological intelligence property. It was flowable solution at room temperature and converted to hydrogel with relatively high tensile strength when it was heated to 37 C. Hence, we suppose that the properties could be suitable for stem cell transplantation.
Low cytotoxicity is very important for the clinical application of biomaterials. Collagen, as the dominating composition of extracellular matrix, could offer a good adhesive surface that promotes cellular attachment, proliferation, and expansion. However, highly hydrated collagen gels exhibit poor structural integrity, which is insufficient for tissue replacement. 17, 18 In this present work, we conjugated type I collagen with copolymer of poly(NIPAAm-co-AAcco-HEMAPCL). And it is demonstrated that the bioconjugation showed improved rigidity according to the storage modulus and viscosity, which may be more suitable for myocardium replacement. In our previous study, it is suggested that the bioconjugation did not change the injectable property of copolymer. Furthermore, this copolymer collagen-based hydrogel exhibited extremely low cytotoxicity for MSCs. 13 Therefore, this tissue-like hydrogel had good biocompatibility for stem cell transplantation in myocardium.
Improved stem cell retention and survival benefit for the cardiac repair. Some evidences suggest that intramyocardial injection allows targeted cell delivery into the areas of interest, but retention of transplanted stem cells in situ can be poor and variable. 4 After injection, cells could be lost and redistributed through the needle tracks, lymphatic vessels, venous vessels, or endocardium, with the retention ratio of 10% to 15% in the myocardium. 19, 20 In this research, we used BLI, a novel and reliable tool to trace transplanted MSCs in live animals. 21 In this study, BLI signals at 2 h, 1 d, and 28 d after MSC transplantation in group 4 were significantly higher than those in group 3. This indicated an improved MSCs retention in myocardium in group 4. Moreover, notable extracardiac signals at liver, spleen, and lung were found in group 3 comparing with group 4. The results also confirmed that the novel hydrogel could diminish redistribution and improve the cell retention in situ. Interestingly, we found highest MSCs distribution in liver than in other organs. The mechanism may be attributed to that the liver expresses high levels of chemoattractant agents, such as stromal derived factor-1. 22 Collectively, this novel hydrogel could effectively keep grafted cells in the targeted site. Furthermore, the number of transplanted cell is a serious concern for stem cell therapy. In previous studies on rodent, number of 1 Â 10 6 was a commonly used cell dosage. 14, 23, 24 In the clinical trials, however, the number of grafted cells ranged from 2.9 Â 10 6 to 6.59 Â 10 8 . 25 Though the optimized number of grafted cells has not been determined yet, we assumed that the hydrogel could load more than 1 Â 10 6 of cells to meet the clinical requirement. However, the maximum number of grafted cells that could be maintained in good shape in the hydrogel still needs to be investigated in future.
MSC transplantation promotes cardiac repair and improves heart function after myocardial infarction through some mechanisms, such as paracrine effect. 26 In the present study, hydrogel-mediated enhancement of cell retention in group 4 may contribute importantly to the improved paracrine effect from the MSCs. As a result, capillary density increased significantly in the peri-infarct region. Moreover, interstitial fibrosis decreased obviously in left ventricle, which could inhibit left ventricle remodeling process. These beneficial cardiac repair eventually improved heart function in group 4. Therefore, we believed that the novel hydrogel-based MSC transplantation could play an important role in cardiac repair. Although hydrogel provided the excellent retention platform for MSCs, it could not ameliorate the harsh microenvironment in ischemic myocardium, which may hinder the long-term survival of transplanted MSCs. Hence, the novel hydrogel loading with oxygen-or growth factor-releasing system is being pursued in the subsequent research to improve the MSC microenvironment.
Conclusion
We developed poly(NIPAAm-co-AAc-co-HEMAPCL)-type I collagen as a thermosensitive and biocompatible hydrogel for MSC transplantation. The hydrogel-mediated MSC transplantation could improve grafted stem cell retention and survival, increase angiogenesis, inhibit left ventricle remodeling, and improve heart function. We believe that this clinically relevant and combined strategy could be of importance for treating patients with myocardial infarction in the future.
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